Sirolimus for Nosebleeds in HHT

Clinical trial NCT05269849 · COMPLETED

Trial details

NCT number: NCT05269849
Sponsor: Unity Health Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia Nosebleeds Epistaxis

Start date: 2022-03-16
Primary completion: 2024-12-02
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.